Skip to main content

Advertisement

Table 1 Patient characteristics (n = 33)

From: Plasma RANTES, IL-10, and IL-8 levels in non–small-cell lung cancer patients treated with EGFR-TKIs

Characteristics Number  
Age, years   
  Median (range) 67 (54–86)
Sex   
  Male/female 18/15  
Performance status   
  0/1/2 2/28/3  
Clinical stage   
  III/IV 6/27  
Histology   
  Ad/Sq/La 29/3/1  
EGFR mutation status   
  Ex18 del/ Ex19 del/ Ex21L858R 1/9/9  
  Negative 9  
  Unknown 5  
Brinkman index   
  Median (range) 370 (0–3840)
Body mass index, Kg/m2   
Median (range) 23.0 (16.0–29.8)
Concomitant disease   
  rheumatoid arthritis 1  
  diabetes mellitus 6  
  hyperlipidemia 6  
  hypertension 17  
Treatment line   
  1st/2nd/more 3/19/11  
  1. EGFR, Epidermal growth factor receptor; Ad, Adenocarcinoma; Sq, Squamous cell carcinoma, La, Large-cell carcinoma; Ex, Exon; del, Deletion.